Tibor Bakacs
Overview
Explore the profile of Tibor Bakacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kerepesi C, Abushukair H, Ricciuti B, Nassar A, Adib E, Alessi J, et al.
JCO Precis Oncol
. 2024 Feb;
8:e2300439.
PMID: 38330262
Purpose: Recent evidence has shown that higher tumor mutational burden strongly correlates with an increased risk of immune-related adverse events (irAEs). By using an integrated multiomics approach, we further studied...
2.
Bakacs T, Sandig V, Kovesdi I
Pharmaceuticals (Basel)
. 2023 Jun;
16(2).
PMID: 37259374
Practically the entire global population is infected by herpesviruses that establish lifelong latency and can be reactivated. Alpha-herpesviruses, herpes simplex viruses 1 and 2 (HSV-1/HSV-2) and varicella zoster virus (VZV),...
3.
Bakacs T, Chumakov K, Safadi R, Kovesdi I
Front Immunol
. 2022 Oct;
13:1046851.
PMID: 36275648
No abstract available.
4.
Bakacs T, Sandig V, Kovesdi I
Cureus
. 2022 Sep;
14(8):e28467.
PMID: 36176842
Background Coronavirus disease 2019 (COVID-19) vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. The problem is that despite such spectacular results, vaccination...
5.
Bakacs T, Sandig V, Slavin S, Gumrukcu S, Hardy D, Renz W, et al.
Infect Disord Drug Targets
. 2022 Apr;
22(7):1-6.
PMID: 35440336
More than 200 viruses infect humans, but treatments are available for less than ten of them. To narrow the gap between 'bugs and drugs,' a paradigm shift is required. The...
6.
Bakacs T, Safadi R, Puskas L, Feher L, Kovesdi I
Cureus
. 2022 Apr;
14(3):e22750.
PMID: 35371882
Based on the recommendation of the International Coalition to Eliminate hepatitis B virus (ICE-HBV), we intend to mimic the spontaneous resolution of HBV infection to achieve a functional cure of...
7.
Bakacs T
Cureus
. 2022 Jan;
13(12):e20303.
PMID: 35024256
Herpes zoster (shingles) is caused by the herpes zoster virus and is characterized by pain and unilateral vesicular rash that typically affects one dermatome. Symptoms tend to resolve over 10-15...
8.
Kleef R, Bacher V, Nagy R, Reisegger P, Bakacs T
Cureus
. 2021 May;
13(4):e14500.
PMID: 34007753
We present a 44-year-old male patient, exposed to tobacco smoke and alcohol, with a locally advanced, multiple recurrent squamous cell carcinoma (SCC) of the vocal cord who had undergone resection...
9.
Corthay A, Bakacs T, Thangavelu G, Anderson C
Semin Cancer Biol
. 2021 Feb;
78:5-16.
PMID: 33582171
Disseminated non-dividing (dormant) cancer cells as well as those in equilibrium with the immune response remain the major challenge for successful treatment of cancer. The equilibrium between disseminated dormant cancer...
10.
Kerepesi C, Bakacs T, Moss R, Slavin S, Anderson C
Cancer Immunol Immunother
. 2020 Mar;
69(5):683-687.
PMID: 32152702
More than 2000 immuno-oncology agents are being tested or are in use as a result of the cancer immunotherapy revolution. Manipulation of co-inhibitory receptors has achieved tumor eradication in a...